|
1
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yoo HY, Patt CH, Geschwind JF and
Thuluvath PJ: The outcome of liver transplantation in patients with
hepatocellular carcinoma in the United States between 1988 and
2001: 5-year survival has improved significantly with time. J Clin
Oncol. 21:4329–4335. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sala M, Fuster J, Llovet JM, Navasa M,
Solé M, Varela M, Pons F, Rimola A, García-Valdecasas JC, Brú C, et
al: High pathological risk of recurrence after surgical resection
for hepatocellular carcinoma: an indication for salvage liver
transplantation. Liver Transpl. 10:1294–1300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoshida Y, Villanueva A, Kobayashi M, Peix
J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, et
al: Gene expression in fixed tissues and outcome in hepatocellular
carcinoma. New Engl J Med. 359:1995–2004. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parisi S, Passaro F, Aloia L, Manabe I,
Nagai R, Pastore L and Russo T: Klf5 is involved in self-renewal of
mouse embryonic stem cells. J Cell Sci. 121:2629–2634. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saxena NK, Sharma D, Ding X, Lin S, Marra
F, Merlin D and Anania FA: Concomitant activation of the JAK/STAT,
PI3K/AKT, and ERK signaling is involved in leptin-mediated
promotion of invasion and migration of hepatocellular carcinoma
cells. Cancer Res. 67:2497–2507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dong JT and Chen C: Essential role of KLF5
transcription factor in cell proliferation and differentiation and
its implications for human diseases. Cell Mol Life Sci.
66:2691–2706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang B, Pan X, Cobb GP and Anderson TA:
MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zimmerman AL and Wu S: MicroRNAs, cancer
and cancer stem cells. Cancer Lett. 300:10–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao T, Li H, Hu Y, Ma D and Cai X: miR-144
suppresses the proliferation and metastasis of hepatocellular
carcinoma by targeting E2F3. Tumor Biol. 35:10759–10764. 2014.
View Article : Google Scholar
|
|
14
|
Ludwig JA and Weinstein JN: Biomarkers in
cancer staging, prognosis and treatment selection. Nat Rev Cancer.
5:845–856. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ozen M, Karatas OF, Gullluoglu S, Bayrak
OF, Sevli S, Guzel E, Ekici ID, Caskurlu T, Solak M, Creighton CJ
and Ittmann M: Overexpression of miR-145-5p inhibits proliferation
of prostate cancer cells and reduces SOX2 expression. Cancer
Invest. 33:251–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Noh JH, Chang YG, Kim MG, Jung KH, Kim JK,
Bae HJ, Eun JW, Shen Q, Kim SJ, Kwon SH, et al: MiR-145 functions
as a tumor suppressor by directly targeting histone deacetylase 2
in liver cancer. Cancer Lett. 335:455–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuen MF, Hou JL and Chutaputti A: Asia
Pacific Working Party on Prevention of Hepatocellular Carcinoma:
Hepatocellular carcinoma in the Asia pacific region. J
Gastroenterol. Hepatol. 24:346–353. 2009.
|
|
20
|
Iliopoulos D, Satra M, Drakaki A,
Poultsides GA and Tsezou A: Epigenetic regulation of hTERT promoter
in hepatocellular carcinomas. Int J Oncol. 34:391–399.
2009.PubMed/NCBI
|
|
21
|
Milazzo M, Fornari F and Gramantieri L:
MicroRNA and hepatocellular carcinoma: Biology and prognostic
significance. Minerva Gastroenterol Dietol. 57:257–271.
2011.PubMed/NCBI
|
|
22
|
Avgeris M, Stravodimos K, Fragoulis EG and
Scorilas A: The loss of the tumour-suppressor miR-145 results in
the shorter disease-free survival of prostate cancer patients. Br J
Cancer. 108:2573–2581. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sanfiorenzo C, Ilie MI, Belaid A, Barlési
F, Mouroux J, Marquette CH, Brest P and Hofman P: Two panels of
plasma microRNAs as non-invasive biomarkers for prediction of
recurrence in resectable NSCLC. PLoS One. 8:e545962013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schee K, Lorenz S, Worren MM, Günther CC,
Holden M, Hovig E, Fodstad O, Meza-Zepeda LA and Flatmark K: Deep
sequencing the microRNA transcriptome in colorectal cancer. PLoS
One. 8:e661652013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tong D, Czerwenka K, Heinze G, Ryffel M,
Schuster E, Witt A, Leodolter S and Zeillinger R: Expression of
KLF5 is a prognostic factor for disease-free survival and overall
survival in patients with breast cancer. Clin Cancer Res.
12:2442–2448. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bateman NW, Tan D, Pestell RG, Black JD
and Black AR: Intestinal tumor progression is associated with
altered function of KLF5. J Biol Chem. 279:12093–12101. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Y, Goldstein BG, Chao HH and Katz JP:
KLF4 and KLF5 regulate proliferation, apoptosis and invasion in
esophageal cancer cells. Cancer Biol Ther. 4:1216–1221. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kwak MK, Lee HJ, Hur K, Park DJ, Lee HS,
Kim WH, Lee KU, Choe KJ, Guilford P and Yang HK: Expression of
Krüppel-like factor 5 in human gastric carcinomas. J Cancer Res
Clin Oncol. 134:163–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
